MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

December 14, 2025 The Spark Weekly 12.14.2025: World Record Pickleball Game and Comets, Christmas, and the Cosmos. Historian Chrissie Senecal joined The Spark to explore how people throughout history ...

Get the detailed quarterly/annual income statement for Optec International, Inc. (OPTI). Find out the revenue, expenses and profit or loss over the last fiscal year.